Clinical Trial
Connect-One: Early Feasibility Study of Connexus Brain-Computer Interface (BCI) to Provide Human Connection Through Communication
ClinicalTrials.gov3/31/2026·03/31/26🌐 USA
Summary
The Connect-One Study is Paradromics' early feasibility study of the Connexus Brain-Computer Interface for patients with impaired communication due to ALS, stroke, or other neuromuscular diseases. The Connexus BCI is a high-data-rate cortical implant designed to decode imagined speech and enable computer device control.
Why it matters
Paradromics aims to achieve industry-leading data throughput with its cortical BCI, potentially enabling more natural and rapid communication than existing systems. As one of the most technically ambitious BCI startups, their first human data will be closely watched.
#BCI#Neural Interfaces#Neural Recording#ALS#Stroke Rehabilitation#USA#First-in-Human
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in